NEURODERM LTD Toevoegen aan een lijst
Inactief instrument
Onderneming Neuroderm Ltd
Aandelen
IL0011334955
Biotechnologie & Medisch Onderzoek
Managers
| Managers | Titel | Leeftijd | Van |
|---|---|---|---|
Kengo Isshiki
CEO | Chief Executive Officer | - | 01-01-20 |
| Director of Finance/CFO | - | 01-01-20 | |
Ofer Ekbali
COO | Chief Operating Officer | - | 01-04-20 |
Uri David
CTO | Chief Tech/Sci/R&D Officer | 98 | 01-10-19 |
Anat Nahmany
HRO | Human Resources Officer | - | 01-01-16 |
Ziva Mesika
LAW | General Counsel | 60 | 01-07-16 |
Besturend
| Besturend | Titel | Leeftijd | Van |
|---|---|---|---|
| Chairman | - | 01-04-20 | |
Mikio Himizu
BRD | Director/Board Member | - | 01-10-17 |
Hitoshi Izaki
BRD | Director/Board Member | - | 01-05-20 |
Kenji Taguchi
BRD | Director/Board Member | - | - |
Aandelenklasse
| Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
|---|---|---|---|---|---|
| Aandeel A | 1 | 26 345 938 | 17 477 028 ( 66,34 %) | 0 | 66,34 % |
Bedrijfsgegevens
NeuroDerm Ltd.
Ruhrberg Science Building Bell Entrance, Rabin Science Park
7670212, Rehovot
+972 8 946 2729
http://www.neuroderm.com
Sector
| Vaira. 1 jan. | Kapi. | |
|---|---|---|
| +6,98% | 111 mld. | |
| +10,87% | 106 mld. | |
| -12,64% | 22,24 mld. | |
| +0,44% | 21,25 mld. | |
| -4,18% | 18,97 mld. | |
| -37,85% | 18,52 mld. | |
| -9,90% | 16,81 mld. | |
| +39,11% | 12,54 mld. | |
| -24,46% | 8,09 mld. |
